(Q36986527)

17 August 2017

title

Lessons from the failure of human papillomavirus vaccine state requirements (English)

1 reference

17 August 2017

1 reference

Schwartz JL

1

1 reference

17 August 2017

Caplan AL

series ordinal

2

1 reference

17 August 2017

Faden RR

series ordinal

3

1 reference

17 August 2017

Sugarman J

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

Clinical Pharmacology & Therapeutics

17 August 2017

published in

1 reference

17 August 2017

volume

82

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

760-763

1 reference

Chapter 2: The burden of HPV-related cancers

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Coming soon: cervical cancer vaccines, and an array of public health issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Mandatory HPV vaccination: public health vs private wealth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Chapter 25: Education, training, and communication for HPV vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Ethical analysis of HPV vaccine policy options

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

The ethics and politics of compulsory HPV vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Nonmedical Exemptions to School Immunization Requirements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Where to begin human papillomavirus vaccination?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Chapter 13: Current findings from prophylactic HPV vaccine trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100397

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100397

1 reference

17 August 2017

1 reference